Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Bergamino MA, López-Knowles E, Morani G, Tovey H, Kilburn L, Schuster EF, Alataki A, Hills M, Xiao H, Holcombe C, Skene A, Robertson JF, Smith IE, Bliss JM, Dowsett M, Cheang MCU; POETIC investigators. Bergamino MA, et al. Among authors: dowsett m. EBioMedicine. 2022 Sep;83:104205. doi: 10.1016/j.ebiom.2022.104205. Epub 2022 Aug 16. EBioMedicine. 2022. PMID: 35985932 Free PMC article.
Aromatase inhibitors in breast cancer.
Smith IE, Dowsett M. Smith IE, et al. Among authors: dowsett m. N Engl J Med. 2003 Jun 12;348(24):2431-42. doi: 10.1056/NEJMra023246. N Engl J Med. 2003. PMID: 12802030 Review. No abstract available.
Circulating tumour cells in breast cancer.
Ring A, Smith IE, Dowsett M. Ring A, et al. Among authors: dowsett m. Lancet Oncol. 2004 Feb;5(2):79-88. doi: 10.1016/S1470-2045(04)01381-6. Lancet Oncol. 2004. PMID: 14761811 Review.
738 results